Paper41295487
In Situ Vaccination by Tumor Ablation: Principles and Prospects for Systemic Antitumor Immunity.
Chikovani T and 1 other. Vaccines (Basel), 2025. Cited by 11 papers, by iCite.
Cite this record
ConductScience Library. In Situ Vaccination by Tumor Ablation: Principles and Prospects for Systemic Antitumor Immunity. Papers, record 41295487. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41295487
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- In Situ Vaccination by Tumor Ablation: Principles and Prospects for Systemic Antitumor Immunity.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References170
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29567707 | CAR T cell immunotherapy for human cancer. | Science | 2018 | https://conductscience.org/library/papers/29567707 | PubMed |
| 2 | 38022658 | Potential biomarkers for predicting immune response and outcomes in lung cancer patients undergoing thermal ablation. | Front Immunol | 2023 | https://conductscience.org/library/papers/38022658 | PubMed |
| 3 | 26214521 | Therapeutic cancer vaccines. | J Clin Invest | 2015 | https://conductscience.org/library/papers/26214521 | PubMed |
| 4 | 18802153 | Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures. | J Clin Oncol | 2008 | https://conductscience.org/library/papers/18802153 | PubMed |
| 5 | 24656178 | Irreversible electroporation for nonthermal tumor ablation in the clinical setting: a systematic review of safety and efficacy. | J Vasc Interv Radiol | 2014 | https://conductscience.org/library/papers/24656178 | PubMed |
| 6 | 25959818 | Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity. | Cell Rep | 2015 | https://conductscience.org/library/papers/25959818 | PubMed |
| 7 | 38687922 | Immunostimulatory effects of thermal ablation: Challenges and future prospects. | J Cancer Res Ther | 2024 | https://conductscience.org/library/papers/38687922 | PubMed |
| 8 | 25858804 | Immune checkpoint blockade: a common denominator approach to cancer therapy. | Cancer Cell | 2015 | https://conductscience.org/library/papers/25858804 | PubMed |
| 9 | 39242811 | High levels of tumor cell-intrinsic STING signaling are associated with increased infiltration of CD8+ T cells in dMMR/MSI-H gastric cancer. | Sci Rep | 2024 | https://conductscience.org/library/papers/39242811 | PubMed |
| 10 | 40629355 | Tumor-derived exosomes and their application in cancer treatment. | J Transl Med | 2025 | https://conductscience.org/library/papers/40629355 | PubMed |
| 11 | 40098962 | Targeting cGAS-STING: modulating the immune landscape of hepatic diseases. | Front Immunol | 2025 | https://conductscience.org/library/papers/40098962 | PubMed |
| 12 | 29567706 | Personalized vaccines for cancer immunotherapy. | Science | 2018 | https://conductscience.org/library/papers/29567706 | PubMed |
| 13 | 25837513 | Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells. | Science | 2015 | https://conductscience.org/library/papers/25837513 | PubMed |
| 14 | 40180765 | Abscopal Effects and Immunomodulation in Skin Cancer Therapy. | Am J Clin Dermatol | 2025 | https://conductscience.org/library/papers/40180765 | PubMed |
| 15 | 26516201 | Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1. | Science | 2015 | https://conductscience.org/library/papers/26516201 | PubMed |
| 16 | 27051417 | Thermal Ablative Therapies and Immune Checkpoint Modulation: Can Locoregional Approaches Effect a Systemic Response? | Gastroenterol Res Pract | 2016 | https://conductscience.org/library/papers/27051417 | PubMed |
| 17 | 34516744 | Tumor-draining lymph nodes: At the crossroads of metastasis and immunity. | Sci Immunol | 2021 | https://conductscience.org/library/papers/34516744 | PubMed |
| 18 | 36761748 | Progress in the cryoablation and cryoimmunotherapy for tumor. | Front Immunol | 2023 | https://conductscience.org/library/papers/36761748 | PubMed |
| 19 | 39848272 | Thermal ablation versus surgical resection of small-size colorectal liver metastases (COLLISION): an international, randomised, controlled, phase 3 non-inferiority trial. | Lancet Oncol | 2025 | https://conductscience.org/library/papers/39848272 | PubMed |
| 20 | 23811849 | Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists. | Cell Death Differ | 2014 | https://conductscience.org/library/papers/23811849 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42897755 | Advances in the Role of Chemokines in Microwave Ablation-Based Combinatorial Immunotherapy. | Cancer Sci | 2026 | https://conductscience.org/library/papers/42897755 | PubMed |
| 42848277 | Ablation-immunotherapy synergy in cancer: mechanisms of the abscopal effect, emerging clinical applications, and translational roadmaps for next-generation onco-immunology. | Med Oncol | 2026 | https://conductscience.org/library/papers/42848277 | PubMed |
| 42707428 | Awakening antitumour immunity in the multimorbid host: a hypothesis coupling cryoablation-induced immunogenic cell death with multi-target Traditional Chinese Medicine. | Front Immunol | 2026 | https://conductscience.org/library/papers/42707428 | PubMed |
| 42666925 | Cryoablation combined with immunotherapy: new strategies and progress in the treatment of tumors. | Front Oncol | 2026 | https://conductscience.org/library/papers/42666925 | PubMed |
| 42602485 | Integrating cryoablation with immunotherapy in non-small cell lung cancer: mechanisms, clinical evidence, and translational barriers. | Front Oncol | 2026 | https://conductscience.org/library/papers/42602485 | PubMed |
| 42589996 | Stage-Adapted Cryotherapy-Based Management of Oral Mucosal Melanoma: A Single-Center Retrospective Cohort. | J Clin Med | 2026 | https://conductscience.org/library/papers/42589996 | PubMed |
| 42506656 | Generating Patient-Specific Anti-Tumor Responses with Non-Genetically Altered 'Off-the-Shelf' Allogeneic Cell Therapy: Leveraging Allo-Incompatibility for In Situ Vaccination. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42506656 | PubMed |
| 42315254 | Mapping the TCR landscape: computational tools empowering translational immunology and therapy design. | J Immunother Cancer | 2026 | https://conductscience.org/library/papers/42315254 | PubMed |
| 42128521 | Local immunotherapy for the treatment of cancer: scientific advances and clinical potential. | J Immunother Cancer | 2026 | https://conductscience.org/library/papers/42128521 | PubMed |
| 42128518 | First-in-human single-cell and TCR atlas reveals peripheral immune remodeling before and after irreversible electroporation in prostate cancer. | J Immunother Cancer | 2026 | https://conductscience.org/library/papers/42128518 | PubMed |
| 41869343 | Risk factors and immune landscape of early local tumor progression after microwave ablation for lung cancer: a retrospective nested case-control study. | Front Immunol | 2026 | https://conductscience.org/library/papers/41869343 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CALR | 811 | PubTator's text mining | https://conductscience.org/library/genes/811 | NCBI Gene |
| CGAS | 115004 | PubTator's text mining | https://conductscience.org/library/genes/115004 | NCBI Gene |
| HMGB1 | 3146 | PubTator's text mining | https://conductscience.org/library/genes/3146 | NCBI Gene |
| STING1 | 340061 | PubTator's text mining | https://conductscience.org/library/genes/340061 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41295487
GET https://conductscience.org/api/papers/v1/41295487/references?page=2